Stay updated on Larotrectinib in NTRK-fusion Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Larotrectinib in NTRK-fusion Solid Tumors Clinical Trial page.

Latest updates to the Larotrectinib in NTRK-fusion Solid Tumors Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedAdded Revision: v3.4.2. Removed the outdated funding notice and the Revision: v3.4.1 reference from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check22 days agoChange DetectedThe history now includes a site-wide funding notice and a revision update to v3.4.1, replacing the former v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check29 days agoChange DetectedThe history now shows a glossary toggle, color-coded change highlights (green for additions and red for deletions), and a new revision tag v3.4.0. The previous revision tag v3.3.4 is removed.SummaryDifference0.4%

- Check42 days agoChange DetectedThe footer now displays Revision: v3.3.4 and no longer shows Revision: v3.3.3.SummaryDifference0.0%

- Check64 days agoChange DetectedAdded Revision: v3.3.3 to the revision history. Removed HHS Vulnerability Disclosure and Revision: v3.3.2 from the page footer.SummaryDifference0.1%

- Check93 days agoChange DetectedFooter revision tag updated from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Larotrectinib in NTRK-fusion Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Larotrectinib in NTRK-fusion Solid Tumors Clinical Trial page.